First-in-Human Study With Single and Multiple Doses of TS-161 in Healthy Participants

NCT03919409 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: TS-161
DRUG: TS-161 Placebo

Sponsor

Taisho Pharmaceutical R&D Inc.